CD9 Antibodies

Santa Cruz Biotechnology features a diverse variety of CD9 monoclonal antibodies for research in cell biology and immunology. CD9 monoclonal antibodies are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CD9 is a tetraspanin protein that plays a crucial role in cell adhesion, migration, and signaling processes. CD9 actively participates in the regulation of immune responses and influences various physiological and pathological conditions, including cancer metastasis and immune system disorders. Understanding CD9 function is essential for elucidating its role in cellular interactions and disease mechanisms. CD9 monoclonal antibodies enable precise detection and analysis of CD9 expression patterns across different cell types and tissues. CD9 monoclonal antibodies support detailed investigation of cellular pathways and molecular mechanisms. Researchers studying CD9-related pathways can leverage Santa Cruz Biotechnology monoclonal antibodies to advance scientific understanding and potentially contribute to therapeutic developments.